Sponsor Pipeline

Renaissance Pharma Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Phase 3
Active Trials by Phase
Phase 2/3
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07549321 A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients High-Risk Neuroblastoma Recruiting
Get alerts when Renaissance Pharma Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free